Parvo vaccine Biosuis L (6) against leptospirosis and parvovirozu inaktyvovavana

Storage

One dose (2 ml) of the vaccine contains:

Active substance:

inactivated parvovirus, CAMP V198, S-27 strain min. 4 log2 titer of HIT *

Leptospira pomona inactivated, MSLB 1037 min. titre 32 for RAL **

Inactivated Leptospira Hardjo, MSLB 1039 min. titre 40 for RAL **

Inactivated Leptospira Bratislava, MSLB 1040 min. titre 40 for RAL **

Inactivated Leptospira grippotyphosa, MSLB 1042 min. titer 51 RAL **

Inactivated Leptospira icterohaemorrhagiae, MSLB 1041 min. titer 51 RAL **

Inactivated Leptospira canicola, MSLB 1043 min. titer 51 RAL **

* Titer antibodies to parvovirus blue found in guinea pigs after administration of a HIT ¼ dose; antibody titer higher than 16 and to the swine parvovirus confirmed their discovery in 4 of 5 guinea pigs

** geometric mean titers value of specific antibodies identified by agglutination lysis (RAL) found in rabbits immunized with a vaccine containing minimal antigen

Excipients:

inaktyvant formaldehyde 35% max. 0.5 mg / ml

preservatives: sodium mertiolat 0.2 mg / dose

Sodium chloride max. 4.5 mg / dose

water for injections max. 0.5 ml / dose

lipid adjuvants to 2 ml

Pharmaceutical form

Emulsion.

Immunobiological properties

Immunization is the formation of specific antibodies that protect embryos gilts and sows parvovirozu against leptospirosis and during the entire period of gestation. High antibody titers after vaccination in hryakiv prevent replication of parvovirus and leptospira in the testes and reduce the risk of transmission during mating. Increasing antibody titers in HIT against parvovirus and lysis-agglutinating antibodies against leptospira serovar each contained in the vaccine occurs after the primary course of vaccination (vaccination and revaccination). In vaccinated animals post-vaccine antibodies maximum levels recorded after 14-28 days after revaccination. In sows and gilts antibodies persist for mating and gestation period in hryakiv - for at least 4 months after the last vaccination.

Type of animal

Pig.

Indications

For the active immunization of sows, gilts and hryakiv against parvovirozu and leptospirosis.

Contraindication

Missing.

Caution when using

Before use, the vial contents heated to a temperature (15-25) ° C and shake thoroughly.

 In place of the vaccine in the muscle can register a slight immune depot. This modified tissue should be removed when testing meat of pigs slaughtered during the period of 14 days after vaccination.

Interaction with other drugs

Information about the harmlessness and efficacy of the vaccine with other veterinary drugs available. The decision to introduce a product with other veterinary medicines directly receives doctor of veterinary medicine.

Cautions during pregnancy, lactation

Not applicable.

Dosage and Administration

The vaccine is used at a dose of 2 ml by intramuscular injection in the neck behind the ear.

Sows and repair pig:

Basic vaccination:

Vaccination 5-6 weeks before mating.

Revacci - 2-3 weeks before mating.

Further regular revaccination always carried a single dose of vaccine 2-3 weeks before mating.

Hryaky:

Basic vaccination:

Vaccination for 5-6 weeks before the first mating or semen collection.

Revacci - 2-3 weeks before the first pairing or attraction hryaka to artificial insemination. To maintain immunity revaktsynuyte always one vaccine dose every 4 months.

Side effects

The product belongs to a group of inactivated vaccines, which usually do not cause adverse effects. When anaphylactic reactions symptomatic treatment is recommended. In place of the vaccine for ear may experience swelling, which disappears within 14 days of vaccination.

Period output (karentsiyi)

Zero days.

Special precautions for staff and service personnel who use VIP

Avoid autovaktsynatsiyi. In case of accidental vaccine should immediately seek medical attention.

Special precautions for disposal of unused VIP, ways of disposal and recycling

Unused veterinary drug or empty bottles should be disposed of in accordance with local requirements.

Expiration date

2 years. The vaccine from an open bottle use within 10 hours.

Storage and transportation

Store in a dry, dark place at a temperature of 2 ° C to 8 ° C. Do not freeze!

Packaging

The vaccine comes in glass bottles. Bottles of vaccines covered with a rubber stopper suitable for piercing and closed aluminum cap, placed in a plastic or cardboard boxes. Each box contains approved card insert.

 Dimensions of packaging:

a) plastic box 10 x 10 ml

b) cartons 1 x 10 ml, 1 x 20 ml, 5 x 20 ml, 1 x 50 ml, 1 x 100 ml.

Name and address of authorization holder and manufacturer

The company "Bioveta" Komenskeho 212 683 23 Ivanovitse on Hane, Czech Republic.

Terms of delivery

Prescription.

Additional Information

If the drug does not comply with the tab cards, or having complications, use this series to immediately stop and notify the State Scientific Control Institute of Biotechnology and strains (DNKIBSHM) and supplier (manufacturer). Along with DNKIBSHM messenger in direct, according to the "Guidelines on the procedure for filing claims against biological agents that are intended for use in veterinary medicine" from 03.06.98 number 2, three unopened vials of the drug in this series at 03151, m. Kyiv, st. Donetsk, 30 DNKIBSHM.